# Natural History Study of ENPP1 Deficiency and the Early-onset Form of ABCC6 Deficiency

> **NCT05050669** · — · COMPLETED · sponsor: **Inozyme Pharma** · enrollment: 12 (actual)

## Conditions studied

- Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency
- ATP-Binding Cassette Subfamily C Member 6 Deficiency
- Generalized Arterial Calcification of Infancy
- Autosomal Recessive Hypophosphatemic Rickets

## Interventions

- **OTHER:** No Intervention for this observational study

## Key facts

- **NCT ID:** NCT05050669
- **Lead sponsor:** Inozyme Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-27
- **Primary completion:** 2023-08-17
- **Final completion:** 2024-06-26
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05050669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05050669, "Natural History Study of ENPP1 Deficiency and the Early-onset Form of ABCC6 Deficiency". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05050669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*